XML 39 R26.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE CAPITAL (Tables)
6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Share Based Compensation by Share Based Payment Award Grants in Period
In the six months ended June 30, 2021 and 2020, the Company granted options and RSU as follows:
Six months ended June 30, 2021
Award
amount*
Exercise price
range*
Vesting periodExpiration
Employees and Directors:
Options957,682 
$5.02-$11.08
1 year -4 years
10 years
RSUs366,678 — 
1 year -4 years
— 
Six months ended June 30, 2020
Award
amount*
Exercise price
range*
Vesting periodExpiration
Employees and Directors:
Options1,195,611 
$7.80-$12.52
1 year -4 years
10 years
RSUs647,427 — 
1 year -4 years
— 
* All amounts and exercise prices for pre-Merger grants are presented following the exchange to Menlo options and RSUs at the Exchange Ratio described in Note 3-Business Combination.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of options granted was computed using the Black-Scholes model. The underlying data used for computing the fair value of the options are as follows:
Six months ended June 30
20212020
Dividend yield%%
Expected volatility
68.38%-69.12%
60.44%-69.83%
Risk-free interest rate
0.5%-1.07%
0.44%-1.26%
Expected term6 years6 years
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table illustrates the effect of share-based compensation on the statements of operations:
Three months ended
June 30
Six months ended
June 30
(in thousands)2021202020212020
Research and development expenses$442 $3,050 $900 $3,566 
Selling, general and administrative1,459 7,718 3,443 8,961 
Total$1,901 $10,768 $4,343 $12,527